Galaxy, a clinical contract research organization, is pleased to announce the launch of its company through a cornerstone product built on its license agreement with Proteome Sciences. (London, UK) and its point of care license of Intellectual Property. For the initial product launch, Galaxy is licensing intellectual property relating to blood biomarkers of stroke developed by Proteome Sciences in partnership with the University of Geneva and Geneva University Hospitals. Galaxy intends to develop and deliver a validated point of onset stroke diagnostic test which will drive a doctor's ability to determine when thrombolytic treatment can be administered for optimum clinical outcomes.
| Website | http://www.galaxyccro.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 2150 S Central Expy Ste 200, Mc Kinney, Texas 75070, US |
| Industry | Business Services General, Business Services |
| Competitors | Fidelity Investments, Schwab Advisor Services, E*TRADE Bank c/o E*TRADE Financial, LLC, Robinhood, TD Ameritrade, Betterment, Apex Clearing, Wealthfront, DriveWealth, Alpaca +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Galaxy CCRO employee's phone or email?
Galaxy CCRO Questions
The Galaxy CCRO annual revenue was $1 million in 2026.
Galaxy CCRO is based in Mc Kinney, Texas.
The NAICS codes for Galaxy CCRO are [54, 541714, 54171, 541, 5417].
The SIC codes for Galaxy CCRO are [87, 873].
